3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Hepatocellular
12
Refractory Solid Tumors
2
Recurrence
2
Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Neurologic Manifestations
1
Neoplasm Metastasis
1
Meningeal Carcinomatosis
1
Liver Neoplasms
1
Kidney Neoplasms
1
HCC
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Interventions
Sorafenib
1
Radiofrequency Ablation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
HCC
×
Sorafenib
×
Clear all
NCT01470495
2017-03-28
REPEAT
Southwest Hospital, China
Phase NA
Unknown
430 enrolled